Bill
HB 2534
Restricts life insurers from using genetic test results in underwriting unless voluntarily submitted and favorable; requires compliance with the Genetic Information Privacy Act.
Note about provided materials
- The packet you supplied contains text from two different bills both numbered HB 2534 (one Arizona bill on ballot collection and one Illinois bill on genetic information and life insurance). This summary focuses on the LIFE INSURANCE — GENETIC INFO provisions (the Illinois text amending the Genetic Information Privacy Act and adding an Insurance Code section), because that matches the bill title you gave. If you want a separate summary of the Arizona ballot-collection language, I can provide that as well.
Summary — HB 2534 (Genetic Information & Life Insurance, Illinois)
Purpose
- To limit how insurers may obtain, use, disclose and act on information derived from genetic testing in the context of life insurance (and to some extent accident & health insurance), and to require insurers to comply with the Genetic Information Privacy Act when issuing or servicing life insurance policies.
Key provisions
- Amend Genetic Information Privacy Act (410 ILCS 513/20):
- Prohibits insurers from seeking information derived from genetic testing for use in connection with life insurance (and generally restricts use for accident and health insurance).
- Defines “underwriting purposes” to include eligibility, premium computation, pre‑existing condition exclusions and other activities related to creating/renewing/replacing coverage.
- Allows an insurer to consider genetic test results only if the individual voluntarily submits those results and the results are favorable to the individual.
- Prohibits insurers from releasing genetic testing information to third parties except as specified in the Act.
- Prohibits direct‑to‑consumer commercial genetic testing companies from sharing a consumer’s genetic test information or other personally identifiable information with any health or life insurer without the consumer’s written consent.
- Add new Insurance Code section (215 ILCS 5/224.5):
- Requires insurers to comply with the Genetic Information Privacy Act in connection with amendment, delivery, issuance, renewal, claims or denials, and premium/rate determinations for life insurance policies.
Who is affected
- Consumers: people who undergo genetic testing gain added protection from insurer access or adverse underwriting based on genetic results (unless they voluntarily submit favorable results).
- Life insurers (and, in some respects, accident & health insurers): must update underwriting, data‑handling, disclosure, and compliance procedures to avoid prohibited uses/sharing of genetic data.
- Direct‑to‑consumer genetic testing companies: prohibited from sharing genetic or personally identifiable consumer information with insurers without written consent.
- Agents/brokers and third parties who handle policy applications, claims, or consumer health data will be subject to restrictions on seeking/receiving genetic test information.
Procedural/timeline notes
- The new Insurance Code duty applies “after the effective date of this amendatory Act of the 104th General Assembly” (i.e., on enactment/effective date specified in the final law).
- The bill text does not specify new criminal penalties beyond the statutory enforcement mechanisms in the Genetic Information Privacy Act; insurers who fail to comply would face remedies provided under that Act and the Insurance Code.
Potential impacts and considerations
- Consumer protection: expands state-level limits on genetic discrimination into life insurance underwriting where federal protections (e.g., GINA) do not apply.
- Insurer practices: may restrict insurers’ access to predictive genetic information, potentially affecting underwriting models and premium setting; insurers may rely more on other medical records or actuarial data.
- Behavioral effects: may encourage more individuals to pursue genetic testing without fear of automatic adverse life-insurance consequences, while preserving insurer access when consumers voluntarily submit favorable results.
- Operational/compliance burden: insurers and genetic testing companies will need written policies, staff training, and consent practices to align with the new restrictions.
If you’d like, I can:
- Produce a side‑by‑side comparison of this bill with current law (Genetic Information Privacy Act and relevant Insurance Code provisions).
- Summarize the separate Arizona HB 2534 (ballot collection) text included in your materials.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
